The designation marks VGA039 as the first drug candidate to receive FDA Fast Track designation for von Willebrand disease.
FDA Grants Fast Track Designation to Star Therapeutics’ VGA039 for von Willebrand Disease
The designation marks VGA039 as the first drug candidate to receive FDA Fast Track designation for von Willebrand disease.